ArticleJournal of experimental & clinical cancer research : CR2019

Preclinical evaluation of 3D185, a novel potent inhibitor of FGFR1/2/3 and CSF-1R, in FGFR-dependent and macrophage-dominant cancer models.

Xia Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.